As a leading diagnostic and clinical trial operation service company specializing in virology and immunology,  Cerba Research provides a wide range of preclinical services to test the safety, effectiveness, PK, and (immune) toxicology of antivirals, drugs, antibodies, and vaccines that target infectious diseases.

With our services, we assist the pharmaceutical, biotech and academic communities from early preclinical research, including in vivo models, through large-scale, late-stage clinical trial programs for vaccines, monoclonal antibodies, and antivirals

Cerba Research also develops tailor-made virological, immunological and molecular assays and is highly experienced in all phases of assay development.

Leverage Cerba Research’s three-decades-plus experience in genomic sequencing to support your research. 

You can rely on Cerba Research to outsource your research questions, including efficacy, safety, passive immunization, immunogenicity, pharmaco kinetics, pathogenicity, antiviral therapy, antiviral prophylaxis, drug delivery, resistance mutants, and more.

Connect with our scientific team to learn how FCM can enhance your research and help you develop the panels you need. 

We’re committed to delivering gold-standard tissue sourcing, processing and analysis services.

Discover our experience in the field of circulatory biomarkers..

At Cerba Research we are specialized on functional and analytical tests downstream of PBMCs isolation. We guarantee customers a high level of quality from sample collection to processing, shipping, handling, storage and analysis worldwide.

Cerba Research has developed unique pipelines specifically for the analysis of viral and microbiome NGS data. Our team of experienced scientists and bioinformaticians work together to provide fully GxP and FDA compliant pipelines that have been scientifically validated. We can help customers to set up data transfer formats following CDISC standards.